Notice of Board Meeting Scheduled to be held on 25th August, 2025.
Notice of 6th Annual General Meeting Scheduled to be held on 29th September, 2025.
Notice of Board Meeting Scheduled to be held on 16th October, 2025.
Notice of Board Meeting Scheduled to be held on 14th November, 2025.
Notice of Board Meeting Scheduled to be held on 05th January, 2026.
Notice of Board Meeting Scheduled to be held on 07th February, 2026.
Notice of Extraordinary General Meeting Scheduled to be held on 28th April, 2026.
Receipt of order dated 22nd July, 2025
Receipt of order dated 31st July, 2025
Outcome of Board Meeting Held on 25th August, 2025.
Receipt of order dated 02nd September, 2025
Outcome and Proceedings of 06TH Annual General Meeting held on 29th September, 2025
Resignation of Company Secretary and Compliance Officer
Resignation of Chief Financial Officer
Outcome of Board Meeting Held on 16th October, 2025.
Outcome of Board Meeting Held on 14th November, 2025.
Setting up of a Second Manufacturing Unit (Unit II) of Pharmaceuticals and Nutraceuticals Products
Outcome of Board Meeting Held on 05th January, 2026.
Commencement of Commercial Production at (Unit II) of Pharmaceuticals and Nutraceutical Products
Resignation of Statutory Auditor
Cancellation of Board Meeting Schedule to be held of 07th February, 2026
Appointment of Statutory Auditor.
Financial Results with Limited Review Report for the half-year ended 30th September, 2025
